OTHER SOLID TUMORS
Clinical trials for OTHER SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new OTHER SOLID TUMORS trials appear
Sign up with your email to follow new studies for OTHER SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new treatment called NT-175 for people with advanced solid tumors (like lung, colon, or breast cancer) that have a specific mutation (TP53 R175H) and a certain immune marker (HLA-A*02:01). NT-175 uses the patient's own T cells, which are modified in…
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New hope for advanced cancer patients: BL-M07D1 enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called BL-M07D1 in 26 adults with advanced digestive tract or other solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it helps shrink tumors. Participa…
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug BL-M05D1 tested in patients with advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug called BL-M05D1 in about 160 adults with advanced or metastatic solid tumors, including stomach, pancreatic, esophageal, and bile duct cancers. The main goals are to find safe doses and understand side effects. Participants must have tried …
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New drug DXC008 enters first human tests for tough cancers
Disease control Recruiting nowThis early-stage study tests a new drug, DXC008, for safety and the right dose in people with prostate cancer or other solid tumors like Ewing sarcoma. About 110 adults who have not responded to standard treatments will take part. The goal is to see if the drug is safe and to get…
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug targets rare genetic cancers in early trial
Disease control Recruiting nowThis study tests a new drug called IDE196 in people with certain cancers that have specific gene mutations (GNAQ/11 or PRKC fusions), including metastatic uveal melanoma and colorectal cancer. The trial has two phases: first to find safe doses, then to see if the drug shrinks tum…
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New registry hopes to unlock secrets of Ultra-Rare childhood cancers
Knowledge-focused Recruiting nowThis study is creating a registry of very rare solid tumors in people aged 1 month to 39 years. Researchers will collect medical records, tumor samples, and survey answers from participants over 5 years. The goal is to gather enough information to better understand these rare can…
Matched conditions: OTHER SOLID TUMORS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:11 UTC